Janssen Inc. et al. v JAMP Pharma Corp.

Call to arrange a consultation

2020

T-769-20

Resolved

New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent Nos. 2,621,273 and 2,659,770 (macitentan)

Counsel to:

JAMP Pharma Corp.

The decision is reported

Partner

Counsel